Pharmicell (005690) - Cash Flow Conversion Efficiency

Latest as of September 2025: 0.080x

Based on the latest financial reports, Pharmicell (005690) has a cash flow conversion efficiency ratio of 0.080x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (₩8.78 Billion ≈ $5.95 Million USD) by net assets (₩110.43 Billion ≈ $74.83 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See Pharmicell defensive liquidity buffer to measure how many days the company can operate on defensive assets alone.

Pharmicell - Cash Flow Conversion Efficiency Trend (2010–2024)

This chart illustrates how Pharmicell's cash flow conversion efficiency has evolved over time, based on yearly financial data.

Pharmicell Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Pharmicell ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
Ta Ann Holdings Bhd KLSE:5012	0.041x
Mutares SE & Co. KGaA XETRA:MUX	-0.145x
Sayona Mining Ltd AU:SYA	0.041x
Cheng Uei Precision Industry Co Ltd TW:2392	0.146x
Qingdao Copton Technology Co Ltd SHG:603798	0.016x
Zhejiang Jihua Group Co Ltd SHG:603980	0.012x
Shenzhen King Brother Electronics Technology Co.Ltd. SHE:301041	N/A
Qurient Co. Ltd KQ:115180	-0.062x

Annual Cash Flow Conversion Efficiency for Pharmicell (2010–2024)

The table below shows the annual cash flow conversion efficiency of Pharmicell from 2010 to 2024. For the full company profile with market capitalisation and key ratios, see 005690 market cap.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2024-12-31	₩86.44 Billion ≈ $58.58 Million	₩3.50 Billion ≈ $2.37 Million	0.040x	-72.46%
2023-12-31	₩80.40 Billion ≈ $54.48 Million	₩11.81 Billion ≈ $8.01 Million	0.147x	+42.35%
2022-12-31	₩76.66 Billion ≈ $51.95 Million	₩7.91 Billion ≈ $5.36 Million	0.103x	+226.26%
2021-12-31	₩63.87 Billion ≈ $43.28 Million	₩-5.22 Billion ≈ $-3.54 Million	-0.082x	-152.00%
2020-12-31	₩57.11 Billion ≈ $38.70 Million	₩8.98 Billion ≈ $6.08 Million	0.157x	+10828.39%
2019-12-31	₩51.52 Billion ≈ $34.91 Million	₩-75.50 Million ≈ $-51.16K	-0.001x	-102.04%
2018-12-31	₩47.49 Billion ≈ $32.18 Million	₩3.40 Billion ≈ $2.31 Million	0.072x	+300.00%
2017-12-31	₩55.99 Billion ≈ $37.95 Million	₩-2.01 Billion ≈ $-1.36 Million	-0.036x	-442.90%
2016-12-31	₩94.60 Billion ≈ $64.11 Million	₩988.97 Million ≈ $670.21K	0.010x	+132.06%
2013-12-31	₩82.42 Billion ≈ $55.86 Million	₩-2.69 Billion ≈ $-1.82 Million	-0.033x	+72.09%
2012-12-31	₩101.58 Billion ≈ $68.84 Million	₩-11.87 Billion ≈ $-8.04 Million	-0.117x	+40.15%
2011-12-31	₩82.82 Billion ≈ $56.13 Million	₩-16.17 Billion ≈ $-10.96 Million	-0.195x	+77.02%
2010-12-31	₩9.90 Billion ≈ $6.71 Million	₩-8.41 Billion ≈ $-5.70 Million	-0.850x	--

About Pharmicell

KO:005690 Korea Biotechnology

Market Cap

$579.46 Million

₩855.06 Billion KRW

Market Cap Rank

#11637 Global

#324 in Korea

Share Price

₩14250.00

Change (1 day)

-3.72%

52-Week Range

₩10460.00 - ₩20250.00

All Time High

₩25150.00